1. Home
  2. OBIO vs TTSH Comparison

OBIO vs TTSH Comparison

Compare OBIO & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • TTSH
  • Stock Information
  • Founded
  • OBIO 2017
  • TTSH 1985
  • Country
  • OBIO United States
  • TTSH United States
  • Employees
  • OBIO N/A
  • TTSH N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • TTSH Blank Checks
  • Sector
  • OBIO Health Care
  • TTSH Finance
  • Exchange
  • OBIO Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • OBIO 291.7M
  • TTSH 319.7M
  • IPO Year
  • OBIO N/A
  • TTSH N/A
  • Fundamental
  • Price
  • OBIO $8.03
  • TTSH $6.98
  • Analyst Decision
  • OBIO Strong Buy
  • TTSH
  • Analyst Count
  • OBIO 2
  • TTSH 0
  • Target Price
  • OBIO $17.00
  • TTSH N/A
  • AVG Volume (30 Days)
  • OBIO 248.3K
  • TTSH 132.5K
  • Earning Date
  • OBIO 08-08-2024
  • TTSH 08-01-2024
  • Dividend Yield
  • OBIO N/A
  • TTSH N/A
  • EPS Growth
  • OBIO N/A
  • TTSH N/A
  • EPS
  • OBIO N/A
  • TTSH 0.21
  • Revenue
  • OBIO $2,216,000.00
  • TTSH $366,855,000.00
  • Revenue This Year
  • OBIO $17.90
  • TTSH $8.17
  • Revenue Next Year
  • OBIO $10.51
  • TTSH N/A
  • P/E Ratio
  • OBIO N/A
  • TTSH $33.24
  • Revenue Growth
  • OBIO N/A
  • TTSH N/A
  • 52 Week Low
  • OBIO $4.22
  • TTSH $4.33
  • 52 Week High
  • OBIO $11.69
  • TTSH $7.67
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 54.75
  • TTSH 52.07
  • Support Level
  • OBIO $7.80
  • TTSH $7.15
  • Resistance Level
  • OBIO $8.87
  • TTSH $7.35
  • Average True Range (ATR)
  • OBIO 0.60
  • TTSH 0.22
  • MACD
  • OBIO -0.01
  • TTSH -0.00
  • Stochastic Oscillator
  • OBIO 59.02
  • TTSH 48.00

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers, and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: